Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.

2.50
Hdl Handle:
http://hdl.handle.net/10029/620967
Title:
Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
Authors:
van Ravenhorst, Mariëtte B; van der Klis, Fiona R M; van Rooijen, Debbie M; Sanders, Elisabeth A M; Berbers, Guy A M
Abstract:
Recently the incidence of meningococcal serogroup Y (MenY) and in particular serogroup W (MenW) invasive disease has risen in several European countries, including the Netherlands. Adolescents are a target group for primary prevention through vaccination to protect against disease and reduce carriage and induce herd protection in the population. The present study assessed MenA, MenW and MenY antibody levels in adolescents up to one year following primary vaccination with quadrivalent MenACWY-PS conjugated to tetanus toxoid (MenACWY-TT).
Citation:
Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination. 2017, 35 (36):4753-4760 Vaccine
Journal:
Vaccine 2017, 35(36):4753-4760
Issue Date:
24-Aug-2017
URI:
http://hdl.handle.net/10029/620967
DOI:
10.1016/j.vaccine.2017.06.007
PubMed ID:
28647167
Type:
Article
Language:
en
ISSN:
1873-2518
Appears in Collections:
Miscellaneous

Full metadata record

DC FieldValue Language
dc.contributor.authorvan Ravenhorst, Mariëtte Ben
dc.contributor.authorvan der Klis, Fiona R Men
dc.contributor.authorvan Rooijen, Debbie Men
dc.contributor.authorSanders, Elisabeth A Men
dc.contributor.authorBerbers, Guy A Men
dc.date.accessioned2018-01-02T14:13:14Z-
dc.date.available2018-01-02T14:13:14Z-
dc.date.issued2017-08-24-
dc.identifier.citationAdolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination. 2017, 35 (36):4753-4760 Vaccineen
dc.identifier.issn1873-2518-
dc.identifier.pmid28647167-
dc.identifier.doi10.1016/j.vaccine.2017.06.007-
dc.identifier.urihttp://hdl.handle.net/10029/620967-
dc.description.abstractRecently the incidence of meningococcal serogroup Y (MenY) and in particular serogroup W (MenW) invasive disease has risen in several European countries, including the Netherlands. Adolescents are a target group for primary prevention through vaccination to protect against disease and reduce carriage and induce herd protection in the population. The present study assessed MenA, MenW and MenY antibody levels in adolescents up to one year following primary vaccination with quadrivalent MenACWY-PS conjugated to tetanus toxoid (MenACWY-TT).en
dc.language.isoenen
dc.rightsArchived with thanks to Vaccineen
dc.titleAdolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.en
dc.typeArticleen
dc.identifier.journalVaccine 2017, 35(36):4753-4760en

Related articles on PubMed

All Items in WARP are protected by copyright, with all rights reserved, unless otherwise indicated.